Feasibility of optimizing pharmacotherapy in heart failure patients admitted to an acute geriatric ward: role of the clinical pharmacist
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/article/10.1007/s41999-017-0019-x/fulltext.html
Reference43 articles.
1. Mosterd A, Hoes AW (2007) Clinical epidemiology of heart failure. Heart 93(9):1137–1146
2. Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, Hofman A et al (1999) Prevalence of heart failure and left ventricular dysfunction in the general population; the Rotterdam Study. Eur Heart J 20(6):447–455
3. Kaila K, Haykowsky MJ, Thompson RB, Paterson DI (2012) Heart failure with preserved ejection fraction in the elderly: scope of the problem. Heart Fail Rev 17(4–5):555–562
4. Stewart S, MacIntyre K, Capewell S, McMurray JJ (2003) Heart failure and the aging population: an increasing burden in the 21st century? Heart 89(1):49–53
5. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J et al (2005) Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26(3):215–225
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Guideline-Directed Medical Therapies for Heart Failure with a Reduced Ejection Fraction in Older Adults: A Narrative Review on Efficacy, Safety and Timeliness;Drugs & Aging;2023-07-14
2. In-Hospital Virtual Peer-to-Peer Consultation to Increase Guideline-Directed Medical Therapy for Heart Failure: A Pilot Randomized Trial;Circulation: Heart Failure;2022-10-31
3. Consensus validation of a screening tool for cardiovascular pharmacotherapy in geriatric patients: the RASP_CARDIO list (Rationalization of Home Medication by an Adjusted STOPP list in Older Patients);European Geriatric Medicine;2022-10-14
4. SGLT2 Inhibitors in Older Adults with Heart Failure with Preserved Ejection Fraction;Drugs & Aging;2022-02-04
5. Clinical Pharmacy Services in Older Inpatients: An Evidence-Based Review;Drugs & Aging;2020-01-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3